Moderna says updated COVID vaccine will be ready for the fall
Maddie Meyer

Moderna (NASDAQ:MRNA) on Thursday said that its updated monovalent COVID-19 vaccine targeting the XBB1.5 Omicron subvariant will be ready for distribution by the fall.
Also, the biotech has submitted to Health Canada a rolling submission to gain authorization of the updated jab in that country.

On June 22, Moderna (MRNA) filed an application for the shot with the US FDA.
Pfizer (PFE), which also has an application pending before the FDA, previously said its new vaccine could be ready by July.
An unanswered question going forward is just how many Americans will get the vaccine. The bivalent vaccine currently being given and made available in fall 2022 has been administered to just 17% of the population as of May, according to the CDC.

More on Moderna

Moderna: Likely To Drop Further (Technical Analysis)
Moderna's Weakness Is Your Opportunity